Abstract
Objective:To simultaneously assess cardiovascular (CV) and gastrointestinal (GI) risk with traditional non-steroidal anti-inflammatory drugs (tNSAIDs) and cyclo-oxygenase 2 (COX-2) inhibitors.Methods:Using the PHARMO Record Linkage System, including drug-dispensing and hospitalisation data...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have